Quick Answer
WINDTREE THERAPEUTICS INC /DE/ reported Diluted EPS of $7.98 per share (loss) for fiscal year 2015.
WINDTREE THERAPEUTICS INC /DE/ Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2015 | -$7.98 | -1.8% |
| 2014 | -$7.84 | -856.1% |
| 2013 | -$0.82 | +13.7% |
| 2012 | -$0.95 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2015 | -$0.20 | -53.8% | -53.8% |
| June 30, 2015 | -$0.13 | +7.1% | +0.0% |
| September 30, 2014 | -$0.13 | +40.9% | +7.1% |
| June 30, 2014 | -$0.14 | +36.4% | +36.4% |
| September 30, 2013 | -$0.22 | +29.0% | +0.0% |
| June 30, 2013 | -$0.22 | -37.5% | +29.0% |
| September 30, 2012 | -$0.31 | — | -93.8% |
| June 30, 2012 | -$0.16 | — | — |
- WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -1.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2015 period, WINDTREE THERAPEUTICS INC /DE/’s diluted eps has declined by 740.0% (from $0.95 per share (loss) to $7.98 per share (loss)).
- The most recent figure is from WINDTREE THERAPEUTICS INC /DE/’s fiscal year 2015 report (Form 10-K), filed with the SEC on March 29, 2016.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: